Thus, we found that a relatively small upregulation of the MBNL proteins can have a profound impact on DM1 phenotypes not only at the level of missplicing but also at histopathology (central nuclei) and functional (myotonia and muscle strength) levels. The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.